Marker Therapeutics Inc (MRKR)

[Phantom Lord]

I'm not worried about bad data. I'm worried that management is making poor decisions in their execution of the release. Ah86 hit the nail on the head. Their problem has always been trickling out data on an inconsequential number of patients. It's great to see the CRs but when the total number of patients you're reporting on is 3, no one is going to care. They need a bigger number. I believe they know this but in my communications with the company they are very reluctant to share the enrollment numbers. That worries me. Originally the trial was supposed to enroll 37 patients. No reason it should not be fully enrolled by now at 37 patients. That being said, back in May the enrollment on clinicaltrials.gov was increased to 79. Take with that what you will. Basically, the company needs data on more patients. They gave us the data on the initial 3 as a "tease" or indicator of how the trial started but the next data release better be at least 30 patients. There is no excuse for anything less than that.